Trial NC-HEM-17-3


A Multicenter, Open-Label, Uncontrolled, Extension Study of RA101495 in Subjects with Paroxysmal Nocturnal Hemoglobinuria Who Have Completed a RA101495 Clinical Study

Type: Treatment
Phase: Phase II
Status: Not Open (Closed)
Treatments: Other
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Ilene Weitz, M.D.
Other Trial Staff:  Christine Duran, Coordinator, Teresa Olea, Coordinator, Donna Fernando, Coordinator, Meena Ibrahim, D.M., Leyla Bojanini, D.M., Maria Dietrich, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.